HTFL$55.361.76%0.955
Heartflow Inc (HTFL)
Date: 2026-11-04 16:00O: 54.59H: 57.30L: 54.53C: 56.49Vol: 1.049M
Heartflow Inc stock is traded at $55.36, with a volume of 463,221. It is up +1.76% in the last 24 hours and up +12.24% over the past month. HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
Previous Close:
$54.40
Open:
$54.59
24h Volume:
463,221
Relative Volume:
0.30
Market Cap:
$4.81B
Revenue:
$191.42M
Net Income/Loss:
-$111.83M
P/E Ratio:
-
EPS:
-$1.33
Net Cash Flow:
-$76.77M
1W Performance:
-6.34%
1M Performance:
+12.24%
6M Performance:
+91.21%
1Y Performance:
+63.34%
1-Day Range:
$54.53$56.87
1-Week Range:
$54.00$60.56
52-Week Range:
$20.13$60.56
Heartflow Inc Stock (HTFL) Company Profile
Name
Heartflow IncSector
HealthcareIndustry
Health Information ServicesPhone
650-241-1221Address
135 MAIN STREET, SUITE 1000, SAN FRANCISCO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
Heartflow Inc Stock (HTFL) Financials Data
Heartflow Inc Stock (HTFL) Insider Trading
- Rogers CampbellOct 22 '26Member of immediate family of
- Transaction
- Proposed Sale
- Cost
- $55.01
- #Shares
- 5,654
- Value ($)
- 311,027
- #Shares Total
- 0
- Rogers CampbellOct 22 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $6.54
- #Shares
- 17,430
- Value ($)
- 114,025
- #Shares Total
- 97,386
- Rogers CampbellOct 22 '26Officer
- Transaction
- Proposed Sale
- Cost
- $55.01
- #Shares
- 23,933
- Value ($)
- 1,316,554
- #Shares Total
- 0
- Rogers CampbellOct 22 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $55.01
- #Shares
- 23,933
- Value ($)
- 1,316,554
- #Shares Total
- 73,453
- Farquhar John C.M.Oct 12 '26Chief Executive Officer
- Transaction
- Sale
- Cost
- $49.57
- #Shares
- 38,900
- Value ($)
- 1,928,195
- #Shares Total
- 283,014
- Farquhar John C.M.Oct 12 '26Officer
- Transaction
- Proposed Sale
- Cost
- $49.57
- #Shares
- 38,900
- Value ($)
- 1,928,195
- #Shares Total
- 0
- Rogers CampbellSep 18 '26Officer
- Transaction
- Proposed Sale
- Cost
- $50.15
- #Shares
- 19,682
- Value ($)
- 987,052
- #Shares Total
- 0
- Rogers CampbellSep 18 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $50.15
- #Shares
- 19,682
- Value ($)
- 987,052
- #Shares Total
- 79,956
- Rogers CampbellSep 18 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $7.94
- #Shares
- 13,179
- Value ($)
- 104,588
- #Shares Total
- 99,638
- Verghese VikramSep 18 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $50.75
- #Shares
- 16,766
- Value ($)
- 850,926
- #Shares Total
- 155,183
